Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension

Journal of Glaucoma

Volumn 10, Issue 5, 2001, Pages 414-422

  Goldberg, Ivan ^a,f   Cunha Vaz, José ^b   Jakobsen, Jan Erik ^c   Nordmann, Jean Philippe ^d   Trost, Elisabeth ^e   Sullivan, E Kenneth ^e  

^a SYDNEY EYE HOSPITAL   (Australia)

^b ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^e Alcon Research Limited   (United States)

^f NONE   (Australia)

Author keywords

Glaucoma; Ocular hypertension; Timolol; Travoprost

Indexed keywords

EYE DROPS; FLUPROSTENOL; PLACEBO; TIMOLOL; TRAVOPROST;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG SAFETY; DRUG TOLERANCE; EYE TOXICITY; HUMAN; HYPEREMIA; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 0035156863     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200110000-00010     Document Type: Article

References (17)

1. Latanoprost: A review of its pharmacological properties, clinical efficacy and tolerability
2. The ocular pharmacokinetics of eicosanoids and their derivatives. I: Comparison of ocular eiconoid penetration and distribution following topical application of F2α-isopropyl ester
3. [3H]AL-5848 ([3H]9beta-(+)-fluprostenol): Carboxylic acid of travoprost (travoprost), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor
4. Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology
5. Mechanism of the prostaglandin-induced reduction of intraocular pressure in humans
6. The mechanism of action of prostaglandins on uveoscleral outflow
7. Pharmacological and clinical aspects of glaucoma therapy
8. Travoprost: A new once-daily dosed prostaglandin for the reduction of elevated intraocular pressure
9. Comparison of Latanoprost and timolol in patients with ocular hypertension and glaucoma - A 6-month, masked, multicenter trial in the United States
10. Points to consider on biostatical/methodological issues arising from recent CPMP discussions on licensing applications: Superior, non-inferiority and equivalence
11. Comparison of the efficacy and safety of 2% Dorzolamide and 0.5% Betaxolol in the treatment of elevated intraocular pressure
12. Safety of betaadrenergic blocker washout period in clinical trials
13. Anterior segment configuration correlated with Shaffer's grading of anterior chamber angle
14. Statistical principles for clinical trials
15. Xalatan Sterile Ophthalmic Solution (Pharmacia-Upjohn)
16. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol
17. Latanoprost and cystoid macular edema: Is there a causal relation?